{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:38:37Z","timestamp":1794573517102,"version":"4.9.1"},"reference-count":125,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2020,10,12]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Immunotherapy is now a cornerstone for cancer treatment, and much attention has been placed on the identification of prognostic and predictive biomarkers. The success of biomarker development is dependent on accurate and timely collection of biospecimens and high-quality processing, storage and shipping. Tumors are also increasingly used as source material for the generation of therapeutic T cells. There have been few guidelines or consensus statements on how to optimally collect and manage biospecimens and source material being used for immunotherapy and related research. The Society for Immunotherapy of Cancer Surgery Committee has brought together surgical experts from multiple subspecialty disciplines to identify best practices and to provide consensus on how best to access and manage specific tissues for immuno-oncology treatments and clinical investigation. In addition, the committee recommends early integration of surgeons and other interventional physicians with expertise in biospecimen collection, especially in clinical trials, to optimize the quality of tissue and the validity of correlative clinical studies in cancer immunotherapy.<\/jats:p>","DOI":"10.1136\/jitc-2020-001583","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T16:25:29Z","timestamp":1605543929000},"page":"e001583","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":35,"title":["Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee"],"prefix":"10.1136","volume":"8","author":[{"given":"Brian","family":"Gastman","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush K","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Chicago, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Berger","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-6173","authenticated-orcid":false,"given":"Genevieve","family":"Boland","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Broderick","sequence":"additional","affiliation":[{"name":"Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA"},{"name":"Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-9844","authenticated-orcid":false,"given":"Lisa H","family":"Butterfield","sequence":"additional","affiliation":[{"name":"Parker Institute for Cancer Immunotherapy, San Francisco, California, USA"},{"name":"Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Byrd","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E","family":"Fecci","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Ferris","sequence":"additional","affiliation":[{"name":"Departments of Otolaryngology, Immunology, and Radiation Oncology, University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Fong","sequence":"additional","affiliation":[{"name":"Department of Surgery, City of Hope National Medical Center, Duarte, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3317-9804","authenticated-orcid":false,"given":"Stephanie L","family":"Goff","sequence":"additional","affiliation":[{"name":"NCI\/SB, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M","family":"Grabowski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Duke Center for Brain and Spine Metastasis, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Ito","sequence":"additional","affiliation":[{"name":"Center for Immunotherapy, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lim","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery, Oncology, Radiation Oncology, and Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Lotze","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Mahdi","sequence":"additional","affiliation":[{"name":"OBGYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokenge","family":"Malafa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Oncology, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Surgery, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-5215","authenticated-orcid":false,"given":"Rogerio I","family":"Neves","sequence":"additional","affiliation":[{"name":"Department of Surgery, Penn State Cancer Institute, Hershey, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle","family":"Odunsi","sequence":"additional","affiliation":[{"name":"Departments of Immunology and Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara I","family":"Pai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Prabhakaran","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragheed","family":"Saoud","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Chicago Hospitals, Chicago, Illinois, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi","family":"Sethuraman","sequence":"additional","affiliation":[{"name":"Nurix Therapeutics Inc, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Skitzki","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology and Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-4373","authenticated-orcid":false,"given":"Craig L","family":"Slingluff","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Oncology, Breast and Melanoma Surgery, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon K","family":"Sondak","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Sunwoo","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Turcotte","sequence":"additional","affiliation":[{"name":"Surgery Department, Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia CS","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA"},{"name":"Immuneering Corp, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"2025100302390074000_8.2.e001583.1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat7807"},{"key":"2025100302390074000_8.2.e001583.2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jtho.2019.12.107","article-title":"PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology Committee","volume":"15","author":"Lantuejoul","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2025100302390074000_8.2.e001583.3","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0178-1"},{"key":"2025100302390074000_8.2.e001583.4","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0243-4"},{"key":"2025100302390074000_8.2.e001583.5","article-title":"Editorial for \"Preoperative Assessment for High-Risk Endometrial Cancer by Developing an MRI- and Clinical-Based Radiomics Nomogram: A Multicenter Study\"","author":"Boscolo-Berto","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"2025100302390074000_8.2.e001583.6","article-title":"Reproducibility of radiomics features derived from intravoxel incoherent motion diffusion-weighted MRI of cervical cancer","author":"Chen","year":"2020","journal-title":"Acta Radiol"},{"key":"2025100302390074000_8.2.e001583.7","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s00261-020-02556-w","article-title":"Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls","volume":"45","author":"Chu","year":"2020","journal-title":"Abdom Radiol"},{"key":"2025100302390074000_8.2.e001583.8","article-title":"Radiomics can predict tumour response in patients treated with nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept","author":"Khene","year":"2020","journal-title":"World J Urol"},{"key":"2025100302390074000_8.2.e001583.9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s11307-020-01487-8","article-title":"Next-Generation Radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms","volume":"22","author":"Shiri","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"2025100302390074000_8.2.e001583.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-020-01163-5","article-title":"Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status","volume":"20","author":"Sudre","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025100302390074000_8.2.e001583.11","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0386"},{"key":"2025100302390074000_8.2.e001583.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0312-8"},{"key":"2025100302390074000_8.2.e001583.13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3161"},{"key":"2025100302390074000_8.2.e001583.14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1494"},{"key":"2025100302390074000_8.2.e001583.15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123791"},{"key":"2025100302390074000_8.2.e001583.16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251102"},{"key":"2025100302390074000_8.2.e001583.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609279"},{"key":"2025100302390074000_8.2.e001583.18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aak9510"},{"key":"2025100302390074000_8.2.e001583.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0040-8"},{"key":"2025100302390074000_8.2.e001583.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0830997100"},{"key":"2025100302390074000_8.2.e001583.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1533209100"},{"key":"2025100302390074000_8.2.e001583.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5716"},{"key":"2025100302390074000_8.2.e001583.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127353"},{"key":"2025100302390074000_8.2.e001583.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203608"},{"key":"2025100302390074000_8.2.e001583.25","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2012.0052"},{"key":"2025100302390074000_8.2.e001583.26","article-title":"Optimization for sequencing and analysis of degraded FFPE-RNA samples","volume":"160","author":"Levin","year":"2020","journal-title":"J Vis Exp"},{"key":"2025100302390074000_8.2.e001583.27","doi-asserted-by":"crossref","unstructured":"Smith CC , Bixby LM , Miller KL , et al . Using RNA sequencing to characterize the tumor microenvironment. In: Thurin M , Cesano A , Marincola FM , et al , eds. Biomarkers for immunotherapy of cancer: methods and protocols. New York, NY: Springer New York, 2020: 245\u201372.","DOI":"10.1007\/978-1-4939-9773-2_12"},{"key":"2025100302390074000_8.2.e001583.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.034"},{"key":"2025100302390074000_8.2.e001583.29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4407"},{"key":"2025100302390074000_8.2.e001583.30","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad7038"},{"key":"2025100302390074000_8.2.e001583.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.010"},{"key":"2025100302390074000_8.2.e001583.32","doi-asserted-by":"crossref","unstructured":"Lin J-R , Izar B , Wang S , et al . Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. eLife 2018;7.doi:10.7554\/eLife.31657","DOI":"10.7554\/eLife.31657"},{"key":"2025100302390074000_8.2.e001583.33","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.191"},{"key":"2025100302390074000_8.2.e001583.34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.7b02716"},{"key":"2025100302390074000_8.2.e001583.35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcancer.2017.09.006","article-title":"The Society for immunotherapy of cancer biomarkers Task force recommendations review","volume":"52","author":"Butterfield","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"2025100302390074000_8.2.e001583.36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3919"},{"key":"2025100302390074000_8.2.e001583.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.028"},{"key":"2025100302390074000_8.2.e001583.38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/annonc\/mdy226","article-title":"Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma","volume":"29","author":"Tetzlaff","year":"2018","journal-title":"Ann Oncol"},{"key":"2025100302390074000_8.2.e001583.39","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-26"},{"key":"2025100302390074000_8.2.e001583.40","doi-asserted-by":"publisher","DOI":"10.1177\/1740774512464438"},{"key":"2025100302390074000_8.2.e001583.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lab.2004.08.003"},{"key":"2025100302390074000_8.2.e001583.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0197-1"},{"key":"2025100302390074000_8.2.e001583.43","unstructured":"Jabbar K , Routbort M , Singh C , et al . Impact of tumor necrosis on success of clinical next generation sequencing. Mod Pathol 2015;28."},{"key":"2025100302390074000_8.2.e001583.44","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0046-4"},{"key":"2025100302390074000_8.2.e001583.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.04.007"},{"key":"2025100302390074000_8.2.e001583.46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41379-019-0383-9","article-title":"Programmed death-ligand 1 expression influenced by tissue sample size. scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European thoracic oncology platform Lungscape cohort","volume":"33","author":"Thunnissen","year":"2020","journal-title":"Mod Pathol"},{"key":"2025100302390074000_8.2.e001583.47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/pros.23087","article-title":"Impact of devascularization and tissue procurement on cell number and RNA integrity in prostatectomy tissue","volume":"75","author":"Payne Ondracek","year":"2015","journal-title":"Prostate"},{"key":"2025100302390074000_8.2.e001583.48","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.5858\/arpa.2019-0009-SA","article-title":"Preanalytics and precision pathology: pathology practices to ensure molecular integrity of cancer patient biospecimens for precision medicine","volume":"143","author":"Compton","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"2025100302390074000_8.2.e001583.49","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2019-0904-SA"},{"key":"2025100302390074000_8.2.e001583.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"2025100302390074000_8.2.e001583.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"2025100302390074000_8.2.e001583.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"2025100302390074000_8.2.e001583.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00587-0"},{"key":"2025100302390074000_8.2.e001583.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32517-X"},{"key":"2025100302390074000_8.2.e001583.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"2025100302390074000_8.2.e001583.56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"2025100302390074000_8.2.e001583.57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716078"},{"key":"2025100302390074000_8.2.e001583.58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtcvs.2018.11.124","article-title":"Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer","volume":"158","author":"Bott","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025100302390074000_8.2.e001583.59","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.8541","article-title":"Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): initial results from a multicenter study (LCMC3)","volume":"36","author":"Rusch","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025100302390074000_8.2.e001583.60","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.8509","article-title":"Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): a phase II multicenter exploratory study\u2014Final data of patients who underwent surgical assessment","volume":"37","author":"Provencio","year":"2019","journal-title":"JCO"},{"key":"2025100302390074000_8.2.e001583.61","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy424.059","article-title":"Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)","volume":"29","author":"Cascone","year":"2018","journal-title":"Ann Oncol"},{"key":"2025100302390074000_8.2.e001583.62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2025100302390074000_8.2.e001583.63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.9901"},{"key":"2025100302390074000_8.2.e001583.64","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9"},{"key":"2025100302390074000_8.2.e001583.65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/diagnostics10010009","article-title":"Current update of laboratory molecular diagnostics advancement in management of colorectal cancer (CRC)","volume":"10","author":"Pang","year":"2020","journal-title":"Diagnostics"},{"key":"2025100302390074000_8.2.e001583.66","article-title":"Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer","author":"Ludford","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2025100302390074000_8.2.e001583.67","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"key":"2025100302390074000_8.2.e001583.68","doi-asserted-by":"publisher","DOI":"10.1038\/35095573"},{"key":"2025100302390074000_8.2.e001583.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.11.012"},{"key":"2025100302390074000_8.2.e001583.70","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0278-7"},{"key":"2025100302390074000_8.2.e001583.71","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00079.2004"},{"key":"2025100302390074000_8.2.e001583.72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/CJI.0000000000000232","article-title":"Understanding microbiome effect on immune checkpoint inhibition in lung cancer: placing the puzzle pieces together","volume":"41","author":"Swami","year":"2018","journal-title":"J Immunother"},{"key":"2025100302390074000_8.2.e001583.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.015"},{"key":"2025100302390074000_8.2.e001583.74","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0574-4"},{"key":"2025100302390074000_8.2.e001583.75","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3610"},{"key":"2025100302390074000_8.2.e001583.76","unstructured":"NCI best practices for Biospecimen resources."},{"key":"2025100302390074000_8.2.e001583.77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7849"},{"key":"2025100302390074000_8.2.e001583.78","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001156"},{"key":"2025100302390074000_8.2.e001583.79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1811067116"},{"key":"2025100302390074000_8.2.e001583.80","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0164-7"},{"key":"2025100302390074000_8.2.e001583.81","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00268-008-9877-1","article-title":"Developing a tissue resource to characterize the genome of pancreatic cancer","volume":"33","author":"Voidonikolas","year":"2009","journal-title":"World J Surg"},{"key":"2025100302390074000_8.2.e001583.82","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.2217\/fon-2016-0243","article-title":"Pancreatic cancer tissue banks: where are we heading?","volume":"12","author":"Balarajah","year":"2016","journal-title":"Future Oncol"},{"key":"2025100302390074000_8.2.e001583.83","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41568-019-0199-4","article-title":"Cancer biology as revealed by the research autopsy","volume":"19","author":"Iacobuzio-Donahue","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2025100302390074000_8.2.e001583.84","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0749-z"},{"key":"2025100302390074000_8.2.e001583.85","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2412"},{"key":"2025100302390074000_8.2.e001583.86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccell.2019.07.001","article-title":"A pharmacogenomic landscape in human liver cancers","volume":"36","author":"Qiu","year":"2019","journal-title":"Cancer Cell"},{"key":"2025100302390074000_8.2.e001583.87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221065","article-title":"Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"2025100302390074000_8.2.e001583.88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1706559114"},{"key":"2025100302390074000_8.2.e001583.89","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1636"},{"key":"2025100302390074000_8.2.e001583.90","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41416-020-0812-z","article-title":"Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases","volume":"122","author":"Stremitzer","year":"2020","journal-title":"Br J Cancer"},{"key":"2025100302390074000_8.2.e001583.91","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J Clin"},{"key":"2025100302390074000_8.2.e001583.92","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fcell.2019.00246","article-title":"Cancer sample biobanking at the next level: combining tissue with living cell Repositories to promote precision medicine","volume":"7","author":"Bolck","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"2025100302390074000_8.2.e001583.93","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.394"},{"key":"2025100302390074000_8.2.e001583.94","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1154"},{"key":"2025100302390074000_8.2.e001583.95","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao2774"},{"key":"2025100302390074000_8.2.e001583.96","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0033-1363839","article-title":"Role of percutaneous needle biopsy for renal masses","volume":"31","author":"Caoili","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"2025100302390074000_8.2.e001583.97","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.178.1.1984314"},{"key":"2025100302390074000_8.2.e001583.98","doi-asserted-by":"crossref","unstructured":"Liu A , Pollard K . Biobanking for personalized medicine. In: Karimi-Busheri F , ed. Biobanking in the 21st century. Cham: Springer International Publishing, 2015: 55\u201368.","DOI":"10.1007\/978-3-319-20579-3_5"},{"key":"2025100302390074000_8.2.e001583.99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2011.01162.x"},{"key":"2025100302390074000_8.2.e001583.100","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-008-0584-y"},{"key":"2025100302390074000_8.2.e001583.101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40661-016-0033-6","article-title":"The role of immune checkpoint inhibition in the treatment of ovarian cancer","volume":"3","author":"Gaillard","year":"2016","journal-title":"Gynecol Oncol Res Pract"},{"key":"2025100302390074000_8.2.e001583.102","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3397"},{"key":"2025100302390074000_8.2.e001583.103","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.5952"},{"key":"2025100302390074000_8.2.e001583.104","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"2025100302390074000_8.2.e001583.105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00057","article-title":"A decade in banking Ewing sarcoma: a report from the children's Oncology Group","volume":"3","author":"Borinstein","year":"2013","journal-title":"Front Oncol"},{"key":"2025100302390074000_8.2.e001583.106","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/pbc.25346","article-title":"A summary of the osteosarcoma banking efforts: a report from the children's Oncology group and the QuadW Foundation","volume":"62","author":"Glover","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2025100302390074000_8.2.e001583.107","unstructured":"Anderson C , ed. Manual for the Examination of Bone. CRC Press, 1982."},{"key":"2025100302390074000_8.2.e001583.108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700850"},{"key":"2025100302390074000_8.2.e001583.109","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-030-12734-3_8","article-title":"Mechanistic justifications of systemic therapeutic oxygenation of tumors to weaken the hypoxia inducible factor 1alpha-mediated immunosuppression","volume":"1136","author":"Hatfield","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2025100302390074000_8.2.e001583.110","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1280"},{"key":"2025100302390074000_8.2.e001583.111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-019-0272-7","article-title":"Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies","volume":"17","author":"Kepp","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025100302390074000_8.2.e001583.112","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191247","article-title":"Effects of interleukin-2 in immunostimulation and immunosuppression","volume":"217","author":"Pol","year":"2020","journal-title":"J Exp Med"},{"key":"2025100302390074000_8.2.e001583.113","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181d32e74"},{"key":"2025100302390074000_8.2.e001583.114","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.998538"},{"key":"2025100302390074000_8.2.e001583.115","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","article-title":"Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Dafni","year":"2019","journal-title":"Ann Oncol"},{"key":"2025100302390074000_8.2.e001583.116","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4939-9773-2_17","article-title":"The Adaptome as biomarker for assessing cancer immunity and immunotherapy","volume":"2055","author":"Han","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2025100302390074000_8.2.e001583.117","doi-asserted-by":"publisher","DOI":"10.1038\/sj.icb.7100055"},{"key":"2025100302390074000_8.2.e001583.118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00263"},{"key":"2025100302390074000_8.2.e001583.119","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.44"},{"key":"2025100302390074000_8.2.e001583.120","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-017-1049-8"},{"key":"2025100302390074000_8.2.e001583.121","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0236"},{"key":"2025100302390074000_8.2.e001583.122","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0489"},{"key":"2025100302390074000_8.2.e001583.123","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0001"},{"key":"2025100302390074000_8.2.e001583.124","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0232-2"},{"key":"2025100302390074000_8.2.e001583.125","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-4042"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-001583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:39:12Z","timestamp":1759484352000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":125,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,16]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/jitc-2020-001583"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-001583","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}